Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
iova · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Buy
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$4.00
-3.0% upside
Low
$2.00
Median: $5 · Last Close: $4.13
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$4.00
-3.0% upside
High Target
$5
21.2%
Low Target
$2
-51.5%
Current Price
$4.13
as of today
Based on analyst price targets, the IOVA stock price prediction for the next 12 months ranges from $2 to $5. The consensus IOVA price forecast of $4.00 implies -3.0% upside from the current price of $4.13.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.30 | ↑ 4.31% |
1-day model range: $4.26–$4.35. Peak: $4.35 (+4.31%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -50.0% |
| 2028 | $2 | -63.8% |
| 2029 | $1 | -69.2% |
| 2030 | $1 | -71.8% |
| 2031 | — | -73.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IOVA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Chardan Capital | Maintains | Buy→Buy |
| 2026-04-10 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-05 | UBS | Maintains | Neutral→Neutral |
| 2026-03-03 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2025-12-17 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-24 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-06 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Iovance Biotherapeutics, Inc. (IOVA) stock. Of the recent 150 rating actions, 9 were upgrades and 11 were downgrades. 20 analysts currently cover IOVA.
Analyst Recommendation Trends
IOVA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$360M
↓ 50.0% YoY
Revenue Next Year
$494M
↑ 37.2% YoY
EPS This Year
$-0.55
EPS Next Year
$-0.31
↓ 43.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast IOVA EPS of $-0.55 for the current fiscal year, based on estimates from 6 analysts. The IOVA revenue forecast is $360M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IOVA stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IOVA price target is $4.00 (-3.0% upside), with an analyst consensus of Buy.
The IOVA short-term stock prediction for tomorrow is $4.30 (+4.31%). The IOVA stock price prediction for 2027 estimates an average of $2. The IOVA stock prediction for 2030 projects a range of $1–$1.
Iovance Biotherapeutics, Inc. trades on NASDAQ under the ticker IOVA. The IOVA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
IOVA forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month IOVA price target is $4.00, with a high forecast of $5.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies -3.0% potential upside from the current price of $4.13.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.